6.7 C
London
Sunday, March 26, 2023
type here...
- Advertisement -spot_img

CATEGORY

The Fly

The Fly

Arvinas price target raised to $77 from $72 at Citi

Frank -
Arvinas price target raised to $77 from $72 at Citi Source link
The Fly

Crispr Therapeutics price target lowered to $55 from $63 at Citi

Frank -
Crispr Therapeutics price target lowered to $55 from $63 at Citi Source link
The Fly

Ideaya Biosciences price target raised to $29 from $26 at Citi

Frank -
Ideaya Biosciences price target raised to $29 from $26 at Citi Source link
The Fly

Ultragenyx price target lowered to $130 from $135 at Citi

Frank -
Ultragenyx price target lowered to $130 from $135 at Citi Source link
The Fly

UBS in talks to buy all or part of Credit Suisse, WSJ reports

Frank -
UBS in talks to buy all or part of Credit Suisse, WSJ reports Source link
The Fly

Takeda kinase 2 inhibitor meets Phase 2 endpoints in psoriasis patients

Frank -
Takeda kinase 2 inhibitor meets Phase 2 endpoints in psoriasis patients Source link
The Fly

Sanofi says moderate-to-severe atopic hand, foot dermatitis trial met endpoints

Frank -
Sanofi says moderate-to-severe atopic hand, foot dermatitis trial met endpoints Source link
The Fly

Buy/Sell: Wall Street’s top 10 stock calls this week

Frank -
Buy/Sell: Wall Street’s top 10 stock calls this week Source link
The Fly

Mogu CEO Qi Chen resigns, Yiming Fan to succeed

Frank -
Mogu CEO Qi Chen resigns, Yiming Fan to succeed Source link
The Fly

Magnite management to meet virtually with Benchmark

Frank -
Magnite management to meet virtually with Benchmark Source link
123...23Page 1 of 23

Latest news

- Advertisement -spot_img

Popular Category

Market News

Editor Picks

Interesting Stuff

2021 © All rights reserved.